Prognostic value of neutrophil-to-lymphocyte ratio in patients with metastatic castration-resistant prostate cancer receiving prostate-specific membrane antigen targeted radionuclide therapy - Stangl-Kremser, J; Sun, M; Ho, B (The Prostate, 2023)